TDSPharm Co., Ltd. (464280) Price & Analysis

― Followers

464280 Stock Chart & Stats

₩4580.00

₩55.00(1.22%)

Jul 31, 2026

―

Day’s Range― - ―

52-Week Range₩4,240.00 - ₩11,650.00

Previous CloseN/A

VolumeN/A

Average Volume (3M)18.70K

Market Cap

₩24.22B

Enterprise ValueN/A

Total Cash (Recent Filing)N/A

Total Debt (Recent Filing)N/A

Price to Earnings (P/E)4.8

Beta0.39

Next EarningsN/A

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)N/A

Shares Outstanding5,530,000

10 Day Avg. Volume19,270

30 Day Avg. Volume18,696

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)N/A

P/FCF RatioN/A

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)1,462,555.07

Revenue Forecast (FY)₩10.00T>

464280 FAQ

What was TDSPharm Co., Ltd.’s price range in the past 12 months?

TDSPharm Co., Ltd. lowest stock price was ₩4240.00 and its highest was ₩11650.00 in the past 12 months.

What is TDSPharm Co., Ltd.’s market cap?

TDSPharm Co., Ltd.’s market cap is ₩24.22B.

When is TDSPharm Co., Ltd.’s upcoming earnings report date?

The company’s upcoming earnings report date is not yet available.

How were TDSPharm Co., Ltd.’s earnings last quarter?

TDSPharm Co., Ltd. released its earnings results on May 14, 2026. The company reported ₩216.765 earnings per share for the quarter, beating the consensus estimate of N/A by ₩216.765.

Is TDSPharm Co., Ltd. overvalued?

According to Wall Street analysts TDSPharm Co., Ltd.’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does TDSPharm Co., Ltd. pay dividends?

TDSPharm Co., Ltd. does not currently pay dividends.

What is TDSPharm Co., Ltd.’s EPS estimate?

TDSPharm Co., Ltd.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does TDSPharm Co., Ltd. have?

TDSPharm Co., Ltd. has 5,530,000 shares outstanding.

What happened to TDSPharm Co., Ltd.’s price movement after its last earnings report?

TDSPharm Co., Ltd. reported an EPS of ₩216.765 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 2.923%.

Which hedge fund is a major shareholder of TDSPharm Co., Ltd.?

Currently, no hedge funds are holding shares in KR:464280

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology